Analysis of glycoprotein I (gI) negative and aberrant pseudorabies viral diagnostic isolates.
Glycoprotein I (gI) phenotypes and genotypes of 4 pseudorabies viral diagnostic isolates were evaluated by use of in vitro DNA amplification, monoclonal antibody binding, gI-specific serodiagnostic responses, and in vivo virulence approaches. Three viruses were avirulent and did not elicit gI-specific serologic responses, react with gI-specific monoclonal antibodies, or contain gI epitope-encoding DNA sequences. The fourth virus was virulent and did elicit a gI-specific serodiagnostic response. Compared with reference virulent pseudorabies viruses, however, the fourth isolate had reduced reactivity with a group of gI monoclonal antibodies and had a single nucleotide sequence substitution with a corresponding putative amino acid change in the epitopically dominant portion of the gI molecule. Presumably, the first 3 isolates represented diagnostic recoveries of viruses derived from gI-deleted modified-live pseudorabies viral vaccines, whereas the fourth isolate was a virulent but gI-aberrant wild-type virus. Thoroughly assessing the gI status of pseudorabies viral diagnostic isolates was considered to be essential in evaluating the epidemiologic importance of these viruses and in monitoring the validity of gI-based vaccine companion tests now used worldwide in pseudorabies control and eradication programs.
Katz
J B
JB
Diagnostic Virology Laboratory, US Department of Agriculture, Ames, IA 50010.
Pederson
J C
JC
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D001483:Base Sequence; D004279:DNA, Viral / Q000235:genetics; D011558:Herpesvirus 1, Suid / Q000302:isolation & purification* / Q000472:pathogenicity; D008969:Molecular Sequence Data; D013552:Swine; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins / Q000032:analysis*; D014765:Viral Vaccines; D014774:Virulence
D000911:Antibodies, Monoclonal; D004279:DNA, Viral; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C042966:pseudorabies virus glycoproteins